Schizophrenia 25 Sep, 2019 Video #6: Which patients are best suited for long-acting injectable antipsychotics? Professor John Kane discusses the often-asked question, who is the ideal candidate for long-acting antipsychotic treatment? Sign up for Progress in Mind Middle East and Africa Sign up for our newsletter and stay updated on new content and resources. Related Schizophrenia Congress highlights Article Do early intervention services impact long-term outcomes in patients with psychosis? Alzheimer's Disease Article Taking a closer look at tau Mental-Health Congress highlights Article A child psychiatrist’s perspective on current treatment options